Ryoji Yoshinaka

Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes

Kohei Kaku, Takahiro Araki, Ryoji Yoshinaka · Diabetes Care · 2012 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.

Ryoji Yoshinaka, Masaaki Shibata, Junji Morimoto et al. · PubMed · 2007 · 71 citations

Medicine, Oncology, Pharmacology +17

Evaluation of cell death and proliferation in psoriatic epidermis

Keisei Kawashima, Hisao Doi, Yuko Ito et al. · Journal of Dermatological Science · 2004 · 60 citations

Life Sciences, Cell Biology, Dermatology +12

Total Parenteral Nutrition via Multilumen Catheters Does Not Increase the Risk of Catheter-Related Sepsis: A Randomized, Prospective Study

T Y, Ryoji Yoshinaka, Amihan P Banaag et al. · Clinical Infectious Diseases · 1998 · 52 citations

Pharmacy, Pharmacotherapy, Parenteral Drug Delivery +7

Intracorporeal stapled anastomosis following laparoscopic segmental gastrectomy for gastric cancer: technical report and surgical outcomes

Sang‐Woong Lee, George Bouras, Eiji Nomura et al. · Surgical Endoscopy · 2009 · 41 citations

Medicine, Oncology, Surgery +17